US FDA is seeking comments on their plan to collect information on Infant Formula Manufacturing, a market that’s expected to reach a revenue of $2.1bn in 2020 (IBISWorld).
Manufacturers can input their opinion on whether this plan is needed; the way to enhance the quality, utility, and clarity of information; and ways to minimize the process.
Contact RegASK for more details Read more
Engaging the right KOLs and creating
impact with your brand